SCHEMBL910653

SCHEMBL910653

CC(=O)NOB(O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.38
ALOX5 P09917 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
ENPP2 Q13822 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
PCSK9 Q8NBP7 1/20 0.38
ORAI1 Q96D31 1/20 0.38
ORAI2 Q96SN7 1/20 0.38
ORAI3 Q9BRQ5 1/20 0.38
TRPV6 Q9H1D0 1/20 0.38
BCAT1 P54687 1/20 0.38
CTRB1 P17538 2/20 0.38
MAPT P10636 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL56442 0.82 ORAI1 (0.39) HSD17B10TSHRCYP3A4CA4CA6
SCHEMBL1711927 0.82 ALDH1A1 (0.45) NAPRTHSD17B10TSHRCA4CA6
SCHEMBL4318570 0.81 F2 (0.33)
SCHEMBL7040701 0.81 ALDH1A1 (0.41) HSD17B10TSHRCYP3A4CA4CA6
Hydrochloric Acid SCHEMBL3987325 0.81 KMT2A (0.41) NAPRTHSD17B10TSHRCA4CA6
SCHEMBL20483698 0.79 ALDH1A1 (0.52) HSD17B10MAPTNPC1RAB9AKMT2A
SCHEMBL1237453 0.78 KMT2A (0.42) NAPRTHSD17B10TSHRCA4CA6
SCHEMBL651370 0.78 ORAI1 (0.42) NAPRTHSD17B10TSHRCYP3A4CA4
SCHEMBL2243245 0.78 ALDH1A1 (0.36) TSHRCA4CA6CA5ACA7
SCHEMBL6517489 0.77 CES1 (0.38) HSD17B10CA4CA6CA5ACA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113621215-B Preparation method of organic-inorganic hybrid biomass phenolic resin ablation-resistant material 哈尔滨工业大学 2024-02-09 CN claimed
CN-114014954-B Hydrophobic decorative base paper and preparation method thereof 华邦特西诺采新材料股份有限公司 2022-10-04 CN claimed
CN-114014954-A Hydrophobic decorative base paper and preparation method thereof 华邦特西诺采新材料股份有限公司 2022-02-08 CN claimed
CN-113621215-A Preparation method of organic-inorganic hybrid biomass phenolic resin ablation-resistant material 哈尔滨工业大学 2021-11-09 CN claimed
US-9340575-B2 Agonists and antagonists of the urotensinergic system INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) 2016-05-17 US claimed
CN-103242989-B A kind of High-stability system enzymatic laundry soap composition and production method thereof GUANGZHOU LIBY ENTERPRISE GROUP CO., LTD. (CN) 2016-03-30 CN claimed
US-8921299-B2 Detergents having acceptable color THE PROCTER & GAMBLE COMPANY (US) 2014-12-30 US claimed
EP-2729184-A1 NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM Institut National de la Recherche Scientifique (CA) 2014-05-14 EP claimed
US-20140113872-A1 NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) 2014-04-24 US claimed
WO-2012149644-A1 NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) 2012-11-08 WO claimed
EP-2059227-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY Aeris Therapeutics, Inc. (US) 2009-05-20 EP claimed
WO-2008039827-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY AERIS THERAPEUTICS, INC. (US) 2008-04-03 WO claimed
US-20260109131-A1 CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES PROCTER & GAMBLE (US) 2026-04-23 US disclosed
US-20260110139-A1 CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES PROCTER & GAMBLE (US) 2026-04-23 US disclosed
EP-4638687-A2 DETERGENT COMPOSITION COMPRISING CATALASE AND AMYLASE Novozymes A/S (DK) 2025-10-29 EP disclosed
EP-4634219-A1 HIGH STRENGTH LIQUID PROTEASE FORMULATIONS Novozymes A/S (DK) 2025-10-22 EP disclosed
WO-1998005627-A1 BORONIC COMPOUND COMPLEXING REAGENTS AND HIGHLY STABLE COMPLEXES PROLINX, INC. (US) 1998-02-12 WO disclosed
WO-1996041859-A1 4-SUBSTITUTED-PHENYL-BORONIC ACIDS AS ENZYME STABILIZERS NOVO NORDISK A/S (DK) 1996-12-27 WO disclosed
EP-0726936-A1 LIQUID DETERGENTS WITH ORTHO-SUBSTITUTED PHENYLBORONIC ACIDS FOR INHIBITION OF PROTEOLYTIC ENZYME THE PROCTER & GAMBLE COMPANY (US) 1996-08-21 EP disclosed
WO-1995012655-A1 LIQUID DETERGENTS WITH ORTHO-SUBSTITUTED PHENYLBORONIC ACIDS FOR INHIBITION OF PROTEOLYTIC ENZYME THE PROCTER & GAMBLE COMPANY (US) 1995-05-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140113872-A1 NOVEL AGONISTS AND ANTAGONISTS OF THE UROTENSINERGIC SYSTEM UTS2R, SCTR, PLAUR NAPRT 1631/4885HSD17B10 4411/4885TSHR 340/4885
US-20260109131-A1 CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES VCAM1, PLOD3, TLN1 NAPRT 3385/4885HSD17B10 3050/4885TSHR 3112/4885
US-20260110139-A1 CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES VCL, PLOD3, ILK NAPRT 3262/4885HSD17B10 2654/4885TSHR 3465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.